Correlation of Endometrial Glycodelin Expression and Pregnancy Outcome in Cases with Polycystic Ovary Syndrome Treated with Clomiphene Citrate Plus Metformin: A Controlled Study

Table 1

Mean distribution of age, BMI, and laboratory values in the study and control groups.

	Study group		Control group
		Mean ± S.D.		Mean ± S.D.
Age (years)	30	25.6 ± 3.78	20	26.5 ± 4.57	0.605
Body Mass Index (kg/m^2)	30	26.24 ± 4.91	20	24.51 ± 3.21	0.019
FSH (mIU/mL)	30	5.74 ± 1.94	20	7.71 ± 2.64	0.005
LH (mIU/mL)	30	10.36 ± 8.68	20	4.6 ± 1.23	0.025
E2 (pg/mL)	30	68.89 ± 74.18	20	46.65 ± 17.8	0.452
Prolactin (ng/mL)	30	10.84 ± 5.06	20	14.46 ± 8.11	0.088
TSH (uIU/mL)	30	2.67 ± 1.51	20	2.41 ± 1.12	0.692
17-OHP (ng/mL)	30	1.59 ± 1.34	20	1.03 ± 0.43	0.088
DHEA-S (ug/dL)	30	247.2 ± 55.4	20	229.7 ± 87.6	0.428
Total testosterone (ng/mL)	30	49.48 ± 20.27	20	48.6 ± 24.24	0.707
Free testosterone (ng/mL)	30	7.20 ± 3.93	20	3.54 ± 1.18	0.002
HDL (mg/dL)	30	43.00 ± 8.73	20	51.25 ± 13.97	0.056
LDL (mg/dL)	30	117 ± 79.84	20	90.25 ± 24.12	0.153
OGTT (mg/dL) (2^hglucose concentration)	30	109.6 ± 35.56	20	110.5 ± 29.2	0.451
Progesterone (pretreatment) (ng/mL)	30	3.84 ± 4.34	20	11.98 ± 5.35	0.001